Verification of molecular subtyping of bladder cancer in the GUSTO clinical trial

• Main Authors: Jon Griffin (Author), Jenny Down (Author), Lewis A Quayle (Author), Paul R Heath (Author), Ewan A Gibb (Author), Elai Davicioni (Author), Yang Liu (Author), Xin Zhao (Author), Jayne Swain (Author), Dennis Wang (Author), Syed Hussain (Author), Simon Crabb (Author), James WF Catto (Author), the GUSTO Trial Management Group (Author)
• Format: Book
• Published: Wiley, 2024-03-01T00:00:00Z.
• Subjects: article
• Online Access: Connect to this object online.

Abstract The GUSTO clinical trial (Gene expression subtypes of Urothelial carcinoma: Stratified Treatment and Oncological outcomes) uses molecular subtypes to guide neoadjuvant therapies in participants with muscle‐invasive bladder cancer (MIBC). Before commencing the GUSTO trial, we needed to deter...